Skip to main content

You are here

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding

The NIH is deeply concerned for the health and safety of people involved in NIH research, and about the effects on the biomedical enterprise in the areas affected by the HHS declared public health emergency for COVID-19. Due to the potential exceptional impact, we want to assure our recipient community that NIH will be doing our part to help you continue your research.

This is a rapidly evolving situation and we will provide updated guidance and information as it becomes available.

See page update history.

Guidance

Overview

Proposal Submission & Award Management

Human Subjects & Clinical Trials

Animal Welfare

Peer Review

  • Based on NIH Guidance on Travel and Meetings Link to Non-U.S. Government Site - Click for Disclaimer, in-person NIH peer review meetings are being held in alternate formats. Scientific review officers will be in contact with peer reviewers about these changes.

FAQs - FAQs last updated on March 30, 2020 (history).

Funding Opportunities Specific to COVID-19

Number

Title

Participating Organizations

Release Date

NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) National Institute on Aging (NIA)
National Institute of Mental Health (NIMH)
April 2, 2020
NOT-HG-20-030 Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus National Human Genome Research Institute (NHGRI) March 31, 2020
NOT-ES-20-014 Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) National Institute of Environmental Health Sciences (NIEHS) March 27, 2020
NOT-TR-20-012 Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) National Center for Advancing Translational Sciences (NCATS) March 27, 2020
NOT-AI-20-034 Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome National Institute of Allergy and Infectious Diseases (NIAID) March 25, 2020
NOT-AI-20-040 Notice of Early Expiration of “Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 National Institute of Allergy and Infectious Diseases (NIAID) March 25, 2020
NOT-GM-20-025 Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 National Institute of General Medical Sciences (NIGMS) March 25, 2020
NOT-TR-20-011 Notice of Special Interest (NOSI) Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Health Need National Center for Advancing Translational Sciences (NCATS) March 24, 2020
NOT-DA-20-047 Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus National Institute on Drug Abuse (NIDA) March 19, 2020
NOT-HL-20-757 Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) National Heart, Lung, and Blood Institute (NHLBI) March 17, 2020
NOT-AI-20-030 Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of General Medical Sciences (NIGMS)
February 6, 2020

Resources

This page last updated on April 2, 2020
Technical Issues: E-mail OER Webmaster